| Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773) |
|---|
| 03/23/2006 | US20060063816 2-Arylbenzothiazole derivatives |
| 03/23/2006 | US20060063815 Polymorphs of an epothilone analog |
| 03/23/2006 | US20060063814 2-[(S)-2-((S)-2,5-dioxo-4-phenyl-imidazolidin-1-yl)-4-methyl-pentanoylamino]-thiazole-4-carboxylic acid methyl ester; mitogen activated protein/extracellular signal regulated kinase kinase inhibitor; anticarcinogenic agent, cognition activator, nervous and autoimmune system disorders |
| 03/23/2006 | US20060063812 Indole derivatives |
| 03/23/2006 | US20060063805 Thiazolinone 4-monosubstituted quinolines |
| 03/23/2006 | US20060063804 Thiazolinone 2-substituted quinolines |
| 03/23/2006 | US20060063796 Pyrazoles as inhibitors of tumor necrosis factor |
| 03/23/2006 | US20060063782 3-Hetero arylmethoxy ! pyridines and their analogues as p38 map kinase inhibitors |
| 03/23/2006 | US20060063771 CCR5 antagonists useful for treating AIDS |
| 03/23/2006 | US20060063765 5-[({[({(2S)-4-[(3,4-dichlorophenyl)methyl]-2-morpholinyl}methyl)amino]carbonyl}amino)methyl]-N-methyl-3-furancarboxamide; free of N-{[4-(3,4-dichlorobenzyl)morpholin-2-yl]methyl}-N'-(2-furylmethyl)urea; CCR3/chemokine recetptor/ antagonists |
| 03/23/2006 | US20060063757 Sulfonamide derivatives as antipsychotic agents |
| 03/23/2006 | US20060063751 Novel fused heterocycles and uses thereof |
| 03/23/2006 | US20060063027 Organic electroluminescent element |
| 03/23/2006 | DE112004000820T5 Verfahren zur Herstellung eines 4,7-Bis(Halogenthien-2-YL)-2,1,3-Benzothiadiazols und eines Vorläufers davon A method for producing a 4,7-bis (halogen Thien-2-yl) -2,1,3-Benzothiadiazols and a precursor thereof |
| 03/23/2006 | CA2581144A1 Novel pyridinone derivatives and their use as positive allosteric modulators of mglur2-receptors |
| 03/23/2006 | CA2580627A1 Nitrate esters and their use for mitigating cellular damage |
| 03/23/2006 | CA2579476A1 Thiazolinone 4-monosubstituted quinolines |
| 03/23/2006 | CA2579348A1 Thiazolinone 2-substituted quinolines |
| 03/23/2006 | CA2579143A1 Vanilloid receptor ligands and their use in treatments |
| 03/23/2006 | CA2579130A1 Substituted hydantoins for the treatment of cancer |
| 03/23/2006 | CA2577181A1 Heteroaroyl-substituted serine amides utilized as herbicides |
| 03/23/2006 | CA2568832A1 Indole derivatives as antiviral agents |
| 03/22/2006 | EP1637530A1 Therapeutic agent for senile dementia |
| 03/22/2006 | EP1637527A1 Cannabinoid receptor modulator |
| 03/22/2006 | EP1637525A1 Benzoxazole compound, process for producing the same, and herbicides |
| 03/22/2006 | EP1637138A2 Use of thiazolidinediones to prevent or delay onset of NIDDM |
| 03/22/2006 | EP1636223A1 Benzothiazole derivatives as adenosine receptor ligands |
| 03/22/2006 | EP1636222A1 7-[(1,3-thiazol-2-yl)thio]-coumarin derivatives and their use as leukotriene biosynthesis inhibitors |
| 03/22/2006 | EP1636221A2 New azetidine compounds |
| 03/22/2006 | EP1636220A1 Isoxazole and isothiazole compounds for the treatment of neurodegenerative disorders |
| 03/22/2006 | EP1636219A1 Novel thiazolylmethyl pyrazoles, method for the production thereof, and use thereof in dyes for keratin fibers |
| 03/22/2006 | EP1636218A1 Thiazolylpiperidine derivatives as mtp inhibitors |
| 03/22/2006 | EP1636217A1 2-imidazo-benzothiazoles as adenosine receptor ligands |
| 03/22/2006 | EP1636216A1 BENZIMIDAZOLE-DERIVATIVES AS FACTOR Xa INHIBITORS |
| 03/22/2006 | EP1636208A1 Inhibitors of serine proteases, particularly hcv ns3-ns4a protease |
| 03/22/2006 | EP1636207A1 Substituted piperidine carbamates for use as inhibitors of hormone sensitive lipase |
| 03/22/2006 | EP1635835A1 2-aminopyrimidine derivatives as raf kinase inhibitors |
| 03/22/2006 | EP1635829A1 8-(3-biaryl)phenylquinoline phosphodiesterase-4-inhibitors |
| 03/22/2006 | EP1635824A2 5-membered heterocycle-based p-38 inhibitors |
| 03/22/2006 | EP1635821A2 4-bromo-5-(2-chloro-benzoylamino)-1h-pyrazole-3-carboxylic acid (phenyl)amide derivatives and related compounds as bradykinin b1 receptor antagonists for the treatment of inflammatory diseases |
| 03/22/2006 | EP1635818A1 Fused indoles as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 03/22/2006 | EP1635800A2 Carbonyl compounds as inhibitors of histone deacetylase for the treatment of disease |
| 03/22/2006 | EP1480951A4 Synthesis of indole thiazole compounds as ligands for the ah receptor |
| 03/22/2006 | EP1406891B1 Thiochromenones used to combat painful conditions and neurodegenerative diseases |
| 03/22/2006 | EP1322635B1 Farnesyl transferase inhibiting quinoline and quinazoline derivatives as farnesyl transferase inhibitors |
| 03/22/2006 | EP1272488B1 Tri-aryl-substituted-ethane pde4 inhibitors |
| 03/22/2006 | EP1140924B1 Piperazine derivatives |
| 03/22/2006 | EP0933379B1 Novel peptide derivatives having thiazolyl-alanine residue |
| 03/22/2006 | CN1751055A Organic metal complex, electroluminescent material using the complex and ectroluminescent element using the complex |
| 03/22/2006 | CN1751039A Pyridine derivatives as fungicidal compounds |
| 03/22/2006 | CN1751038A Substituted aryl and heteroaryl derivatives as modulators of glucose metabolism and the prophylaxis and treatment of disorders thereof |
| 03/22/2006 | CN1751025A Diamine derivatives |
| 03/22/2006 | CN1750823A Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 03/22/2006 | CN1750820A Thiazole and oxazole derivatives which modulate PPAR activity |
| 03/22/2006 | CN1245938C Novel dyeing composition for dyeing-keratinous fibers comprising particular dicationic diazo dye |
| 03/21/2006 | US7015321 Synthesis of non-symmetrical sulfamides using burgess-type reagents |
| 03/21/2006 | US7015241 Appetite-stimulating agents and remedies for anorexia |
| 03/21/2006 | US7015230 serine protease inhibitors comprising pyrimidinediones, used as anticoagulants for prophylaxis of cardiovascular disorders; thrombolytic agents |
| 03/21/2006 | US7015229 An antagonist of a corticotropin releasing factor (CRF) receptor, treating central nervous system disorders or anxiety disorders, depression and stress |
| 03/21/2006 | US7015220 enzyme inhibitors used as modulators of tyrosine kinase signal transduction and/or as antiproliferative agents; prophylaxis of vision defects, cancer, atherosclerosis, restenosis, metabolic disorders or autoimmune diseases |
| 03/21/2006 | US7014968 Which have good electrostatic properties such as high acceptance voltage and low discharge voltage; electrophotographic apparatuses and imaging methods; 9-(thiiranylmethyl)-3,3'-bicarbazole for example |
| 03/21/2006 | CA2242416C Sulfonated amino acid derivatives and metalloproteinase inhibitors containing the same |
| 03/21/2006 | CA2238816C N-acyl-2-substituted-4-(benzimidazolyl- or imidazopyridinyl-substituted residues)-piperidines as tachykinin antagonists |
| 03/21/2006 | CA2178949C Morpholine and thiomorpholine tachykinin receptor antagonists |
| 03/21/2006 | CA2134625C Substituted pyridylsalicylaldehyde or -salicylic acid derivatives, their preparation and their use as herbicides |
| 03/16/2006 | WO2006028970A1 Derivatives of thiazole and thiadiazole inhibitors of tyrosine phosphatases |
| 03/16/2006 | WO2006028958A2 Pyridyl inhibitors of hedgehog signalling |
| 03/16/2006 | WO2006028957A1 4-substituted 4, 6-dialkoxy-cinnoline derivatives as phospodiesterase 10 inhibitors for the treatment of psychiatric or neurological syndroms |
| 03/16/2006 | WO2006028284A1 Morpholine compound |
| 03/16/2006 | WO2006028269A2 Thiazole derivatives having vap-1 ihibitory activity |
| 03/16/2006 | WO2006028226A1 Novel imidazolidine derivative and use thereof |
| 03/16/2006 | WO2006027628A2 Naphthalimide derivatives as antiviral agents |
| 03/16/2006 | WO2006027142A1 Substituted phenylaminothiazoles and use thereof |
| 03/16/2006 | WO2006026934A1 Method for the preparation of rosiglitazone |
| 03/16/2006 | WO2006015004A3 White light-emitting electroluminescent device |
| 03/16/2006 | WO2005121121A3 Substituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto |
| 03/16/2006 | WO2005100349A3 Polycyclic pyridines as potassium ion channel modulators |
| 03/16/2006 | US20060058523 Quinazoline compounds |
| 03/16/2006 | US20060058522 2-[(aminocarbonyl)amino]-5-(4-{[2,2,2-trifluoroethyl)amino]methyl}phenyl)thiophene-3-carboxamide; I kappa B kinase-1(IKK-1) inhibitors; asthma, rheumatoid arthritis, psoriasis, inflammatory bowel disease, multiple sclerosis, chronic obstructive pulmonary disease, bone resorptive disease, osteoarthritis |
| 03/16/2006 | US20060058353 Benzofuran derivatives, process for their preparation and intermediates thereof |
| 03/16/2006 | US20060058314 Oxazolidinone derivatives and their use as antibacterial agents |
| 03/16/2006 | US20060058309 Respiratory syncytial virus replication inhibitors |
| 03/16/2006 | US20060058292 2,4-pyrimidinediamine compounds and their uses |
| 03/16/2006 | US20060058289 Mercaptoimidazoles as ccr2 receptor antagonists |
| 03/16/2006 | US20060058246 Macrolide compounds endowed with antiinflammatory activity |
| 03/16/2006 | US20060057068 CA IX-specific inhibitors |
| 03/16/2006 | DE102004043826A1 Mixture of two metal azo complexes useful as a light absorber in the information layer of a write-once optical data carrier |
| 03/16/2006 | CA2579889A1 Thiazole derivatives having vap-1 inhibitory activity |
| 03/16/2006 | CA2579886A1 Novel imidazolidine derivative and use thereof |
| 03/16/2006 | CA2579621A1 Substituted piperazine compounds and their use as fatty acid oxidation inhibitors |
| 03/16/2006 | CA2578996A1 4-substituted 4, 6-dialkoxy-cinnoline derivatives as phospodiesterase 10 inhibitors for the treatment of psychiatric or neurological syndroms |
| 03/15/2006 | EP1634876A2 Heterocyclic compounds for the treatment of hyperlipidemia agents |
| 03/15/2006 | EP1633747A1 Tetrahydroisoquinoline derivatives as ppar-a activators |
| 03/15/2006 | EP1633743A1 Cyclic amine derivatives and their use in the treatment of inflammation-related disorders mediated by bradykinin |
| 03/15/2006 | EP1633740A2 Chemical compounds |
| 03/15/2006 | EP1633735A1 Derivatives of piperidinyl- and piperazinyl-alkyl carbamates, preparation methods thereof and application of same in therapeutics |
| 03/15/2006 | EP1633733A1 Cannabinoid derivatives, methods of making, and use thereof |
| 03/15/2006 | EP1633732A1 Benzyl sulfonamide derivatives as androgen receptor antagonists |
| 03/15/2006 | EP1633730A1 N-alkynyl-2-heteroaryloxyalkylamides for use as fungicides |
| 03/15/2006 | EP1633729A1 Sulphonamide compounds that modulate chemokine receptor activity (ccr4) |